Money Lancer
Equity: Sectoral-Pharma and Healthcare
SBI Mutual Fund
SBI Mutual Fund · Equity: Sectoral-Pharma and Healthcare

SBI Healthcare Opportunities Fund - Regular Plan -Growth

To provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

EquityBenchmark · BSE Healthcare TRITER · 1.88%Inception · 14-07-1999
NAV
504.90
+0.63% · as of 15-07-2026
Since inception
15.62%
CAGR
Benchmark (inception)
15.01%
CAGR
Fund size
₹4,998 Cr
AUM
Expense ratio
1.88%
31-05-2026
Performance

Returns vs benchmark & category

Since inception: +15.62% CAGR vs benchmark +15.01%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-11.03%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-6.57%
Ami Organics Limited6.17%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.37%
MAX HEALTHCARE INSTITUTE LIMITED EQ4.76%
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-3.90%
ASTER DM HEALTHCARE LIMITED EQ3.83%
LAURUS LABS LIMITED EQ NEW FV RS. 2/-3.58%
BIOCON LIMITED EQ3.52%
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-3.48%

Sector allocation

Healthcare92.70%
Chemicals2.65%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 15.6% p.a.
₹10,000
10 years
Projected value
₹28,95,488
Invested: ₹12,00,000
Gained: ₹16,95,488
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
M
Mr. Tanmaya Desai
Manager since fund inception data not available
ISIN & identifiers
AMFI code
102823
ISIN (Growth)
INF200K01446
ISIN (Div Re-inv)
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us